Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates

Simone Mok(Trinity College Dublin), Thomas R. Rogers(Scripps Research Institute), Anne Marie McLaughlin(St. James's Hospital), Margaret Fitzgibbon(Trinity College Dublin), Patrick J. Stapleton(Mater Misericordiae University Hospital), Philip G. Murphy(University of Ulster), Margaret M. Hannan(Mater Misericordiae Hospital), Eleanor McNamara(Health Service Executive), Niamh O’Sullivan(Our Lady's Hospital), Lars Nölke(Mater Misericordiae University Hospital)
Antimicrobial Agents and Chemotherapy
June 27, 2019
10.1128/aac.00755-19
Cited by 18

Related Papers

Use of probiotic <i>Lactobacillus</i> preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial
|BMJ|2007|591
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426
2019 EACTS Expert Consensus on long-term mechanical circulatory support
|European Journal of Cardio-Thoracic Surgery|2019|388